微门户首页  新闻  讨论区  活动  博客  求职招聘  行业报告  圈内成员  供应   
已读[23] 发布: 2013/07/06 19:03:20
Daily Mail Dr Oluwatoyin Ogunsanya, Dr Atef Wissa, and Dr Adegbnoyega Tayo respectively prescribed him 20mgs of anti-depressant citalopram and sleeping tablets as his speech progressively worsened to the point of being 'almost mute'. Mr Buckley Snr raised the  ... and more »
已读[25] 发布: 2013/07/06 19:03:10
International Business Times Lundbeck immediately vowed an appeal, saying its patent rights to Citalopram are valid, have been confirmed by the European Patent Office ...
已读[250] 发布: 2013/07/06 19:00:14
1、目前一线的抗抑郁剂包括SSRI类药物,如帕罗西汀、舍曲林、氟西汀、西酞普兰、氟伏沙明等,俗称“五朵金花”,SSRI类不良反应较少而轻微,尤其是抗胆碱能及...
已读[181] 发布: 2013/07/04 23:18:10
Breitbart博士指出,对于临终的癌症患者,应尽可能选择文拉法辛、米氮平、西酞普兰、依地普仑等药物,因为这些药物对细胞色素P450系统的影响很小,所以不太可能干扰他...
已读[52] 发布: 2013/07/03 21:05:11
Psychiatric News The authors also looked at more than 350,000 patients who took sertraline , an SSRI that does not carry an FDA warning for QT prolongation or torsade de pointes. As was the case with citalopram, high-dose sertraline (>100 mg daily) was associated with  ...
已读[22] 发布: 2013/06/22 13:47:39
欧盟反垄断机构周三的声明称,在灵北制药厂的西酞普兰专利到期之后,灵北向其它多家制药厂支付数千万欧元要求它们不进入市场,并购买仿制药公司库存,而唯一目的就是销毁西酞普兰仿制药。 “一家公司为谋求竞争对手不进入市场、阻挠低价药进入市场而向其付钱是不可接受的,”...
已读[24] 发布: 2013/06/22 13:47:36
Eversheds Press Office (press release) Without the existence of the “pay-for-delay” agreements it is likely that all four of the generic drug companies would have launched their own drugs in competition with Citalopram , which would have resulted in dramatically cheaper drugs for the ...
已读[24] 发布: 2013/06/22 13:47:32
European Voice The Commission says the companies agreed on delaying the market entry of cheaper versions of a leading Lundbeck product, citalopram , in breach of European Union anti-trust rules that prohibit anti-competitive agreements. Almunia said: "It is ...
已读[22] 发布: 2013/06/22 13:47:28
International IP and the Public Interest The EC found a violation of Article 101 of the Treaty on the Functioning of the European Union (TFEU) as a result of Lundbeck's ...
已读[22] 发布: 2013/06/22 13:47:08
EUobserver.com BRUSSELS - The European Commission has fined Danish pharmaceutical firm Lundbeck €93.8 million, saying it paid rival companies to delay production of generic versions of anti-depressant medication Citalopram . It is the first "pay for delay" case ...
« 上一页  |   查看结果51-60共189   |  下一页 »

新闻标签:

没有标签


最新报告


求职招聘